Search Results - "Belinsky, Martin"

Refine Results
  1. 1
  2. 2

    The MRP family of drug efflux pumps by Kruh, Gary D, Belinsky, Martin G

    Published in Oncogene (20-10-2003)
    “…The MRP family is comprised of nine related ABC transporters that are able to transport structurally diverse lipophilic anions and function as drug efflux…”
    Get full text
    Journal Article
  3. 3

    organic solute transporter α-β, Ostα-Ostβ, is essential for intestinal bile acid transport and homeostasis by Rao, Anuradha, Haywood, Jamie, Craddock, Ann L, Belinsky, Martin G, Kruh, Gary D, Dawson, Paul A

    “…The apical sodium-dependent bile acid transporter (Asbt) is responsible for transport across the intestinal brush border membrane; however, the carrier(s)…”
    Get full text
    Journal Article
  4. 4

    Combination of Imatinib Mesylate and AKT Inhibitor Provides Synergistic Effects in Preclinical Study of Gastrointestinal Stromal Tumor by Zook, Phillip, Pathak, Harsh B, Belinsky, Martin G, Gersz, Lawrence, Devarajan, Karthik, Zhou, Yan, Godwin, Andrew K, von Mehren, Margaret, Rink, Lori

    Published in Clinical cancer research (01-01-2017)
    “…Gastrointestinal stromal tumors (GIST) generally harbor activating mutations in the receptor tyrosine kinase KIT or in the related platelet-derived growth…”
    Get full text
    Journal Article
  5. 5

    Succinate dehydrogenase deficiency in a PDGFRA mutated GIST by Belinsky, Martin G, Cai, Kathy Q, Zhou, Yan, Luo, Biao, Pei, Jianming, Rink, Lori, von Mehren, Margaret

    Published in BMC cancer (02-08-2017)
    “…Most gastrointestinal stromal tumors (GISTs) harbor mutually exclusive gain of function mutations in the receptor tyrosine kinase (RTK) KIT (70-80%) or in the…”
    Get full text
    Journal Article
  6. 6

    Succinate dehydrogenase deficiency in pediatric and adult gastrointestinal stromal tumors by Belinsky, Martin G, Rink, Lori, von Mehren, Margaret

    Published in Frontiers in oncology (01-01-2013)
    “…Gastrointestinal stromal tumors (GISTs) in adults are generally driven by somatic gain-of-function mutations in KIT or PDGFRA, and biological therapies…”
    Get full text
    Journal Article
  7. 7

    Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors by Belinsky, Martin G., Rink, Lori, Flieder, Douglas B., Jahromi, Mona S., Schiffman, Joshua D., Godwin, Andrew K., Mehren, Margaret von

    Published in Genes chromosomes & cancer (01-02-2013)
    “…Approximately 15% of gastrointestinal stromal tumors (GISTs) in adults and 85% in children lack mutations in KIT and PDGFRA and are known as wild‐type GISTs…”
    Get full text
    Journal Article
  8. 8

    ABCC10, ABCC11, and ABCC12 by Kruh, Gary D, Guo, Yanping, Hopper-Borge, Elizabeth, Belinsky, Martin G, Chen, Zhe-Sheng

    Published in Pflügers Archiv (01-02-2007)
    “…Multidrug resistance protein (MRP)7, MRP8, and MRP9 (gene symbols ABCC10, ABCC11, and ABCC12) are recently identified members of the MRP family that are at…”
    Get full text
    Journal Article
  9. 9

    Somatic loss of function mutations in neurofibromin 1 and MYC associated factor X genes identified by exome-wide sequencing in a wild-type GIST case by Belinsky, Martin G, Rink, Lori, Cai, Kathy Q, Capuzzi, Stephen J, Hoang, Yen, Chien, Jeremy, Godwin, Andrew K, von Mehren, Margaret

    Published in BMC cancer (10-11-2015)
    “…Approximately 10-15 % of gastrointestinal stromal tumors (GISTs) lack gain of function mutations in the KIT and platelet-derived growth factor receptor alpha…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): Resistance to docetaxel by HOPPER-BORGE, Elizabeth, CHEN, Zhe-Sheng, SHCHAVELEVA, Irina, BELINSKY, Martin G, KRUH, Gary D

    Published in Cancer research (Chicago, Ill.) (15-07-2004)
    “…The multidrug resistance protein (MRP) family consists of nine members that can be categorized according to whether or not a third (NH(2)-terminal)…”
    Get full text
    Journal Article
  12. 12

    Contribution of Abcc10 (Mrp7) to In Vivo Paclitaxel Resistance as Assessed in Abcc10-/- Mice by HOPPER-BORGE, Elizabeth A, CHURCHILL, Timothy, KLEIN-SZANTO, Andres J, BELINSKY, Martin G, KRUH, Gary D, PAULOSE, Chelsy, NICOLAS, Emmanuelle, JACOBS, Joely D, NGO, Olivia, YEHONG KUANG, GRINBERG, Alex, WESTPHAL, Heiner, CHEN, Zhe-Sheng

    Published in Cancer research (Chicago, Ill.) (15-05-2011)
    “…Recently, we reported that the ATP-binding cassette transporter 10 (ABCC10), also known as multidrug resistance protein 7 (MRP7), is able to confer resistance…”
    Get full text
    Journal Article
  13. 13

    Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6) by BELINSKY, Martin G, CHEN, Zhe-Sheng, SHCHAVELEVA, Irina, HAO ZENG, KRUH, Gary D

    Published in Cancer research (Chicago, Ill.) (01-11-2002)
    “…Mutations in human multidrug resistance protein 6 (MRP6, ABCC6), a member of the MRP family of drug efflux pumps, are the genetic basis of Pseudoxanthoma…”
    Get full text
    Journal Article
  14. 14

    Physiological and pharmacological functions of Mrp2, Mrp3 and Mrp4 as determined from recent studies on gene-disrupted mice by Kruh, Gary D, Belinsky, Martin G, Gallo, James M, Lee, Kun

    Published in Cancer and metastasis reviews (01-03-2007)
    “…The MRP family is composed of nine transporters, at least eight of which are lipophilic anion transporters that are capable of conferring resistance to various…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Analysis of the in vivo functions of Mrp3 by Belinsky, Martin G, Dawson, Paul A, Shchaveleva, Irina, Bain, Lisa J, Wang, Renxue, Ling, Victor, Chen, Zhe-Sheng, Grinberg, Alex, Westphal, Heiner, Klein-Szanto, Andres, Lerro, Anthony, Kruh, Gary D

    Published in Molecular pharmacology (01-07-2005)
    “…Multidrug resistance protein 3 (MRP3) is an ATP-binding cassette transporter that is able to confer resistance to anticancer agents such as etoposide and to…”
    Get more information
    Journal Article
  17. 17

    Combined Inhibition of AKT and KIT Restores Expression of Programmed Cell Death 4 (PDCD4) in Gastrointestinal Stromal Tumor by Kozinova, Marya, Joshi, Shalina, Ye, Shuai, Belinsky, Martin G, Sharipova, Dinara, Farma, Jeffrey M, Reddy, Sanjay S, Litwin, Samuel, Devarajan, Karthik, Campos, Alex Rosa, Yu, Yi, Schwartz, Brian, von Mehren, Margaret, Rink, Lori

    Published in Cancers (23-07-2021)
    “…The majority of gastrointestinal stromal tumor (GIST) patients develop resistance to the first-line KIT inhibitor, imatinib mesylate (IM), through acquisition…”
    Get full text
    Journal Article
  18. 18

    Transport of bile acids, sulfated steroids, estradiol 17-beta-D-glucuronide, and leukotriene C4 by human multidrug resistance protein 8 (ABCC11) by Chen, Zhe-Sheng, Guo, Yanping, Belinsky, Martin G, Kotova, Elena, Kruh, Gary D

    Published in Molecular pharmacology (01-02-2005)
    “…We previously determined that expression of human multidrug resistance protein (MRP) 8, a recently described member of the MRP family of ATP-binding cassette…”
    Get more information
    Journal Article
  19. 19

    Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10) by Chen, Zhe-Sheng, Hopper-Borge, Elizabeth, Belinsky, Martin G, Shchaveleva, Irina, Kotova, Elena, Kruh, Gary D

    Published in Molecular pharmacology (01-02-2003)
    “…Human multidrug resistance protein 7 (MRP7, ABCC10) is a recently described member of the C family of ATP binding cassette proteins (Cancer Lett 162:181-191,…”
    Get more information
    Journal Article
  20. 20

    Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor by Rink, Lori, Skorobogatko, Yuliya, Kossenkov, Andrew V, Belinsky, Martin G, Pajak, Thomas, Heinrich, Michael C, Blanke, Charles D, von Mehren, Margaret, Ochs, Michael F, Eisenberg, Burton, Godwin, Andrew K

    Published in Molecular cancer therapeutics (01-08-2009)
    “…Despite initial efficacy of imatinib mesylate in most gastrointestinal stromal tumor (GIST) patients, many experience primary/secondary drug resistance…”
    Get full text
    Journal Article